The tirzepatide vs semaglutide dosage chart and our head-to-head comparison cover the cost-effectiveness tradeoffs between these two GLP-1 medications in detail
A position statement of the World Obesity Federation
The same drug goes for as much as $349 a month in the US without insurance (where patents dont expire until 2032)
Headache is a recognized Wegovy adverse reaction, but a headache occurring during treatment is not necessarily a migraine or proof that semaglutide triggered it
Formulation, Cost, and Access: A Practical Comparison Framework Cost, convenience, and insurance coverage significantly influence real-world medication selection
Its FDA-approved for helping manage type 2 diabetes, but Currently, injectable semaglutide (Wegovy) is FDA-approved for weight management